Investing Profile

Maha Katabi

InvestorVC
General Partner at Sofinnova Investments
sofinnova.com/team/maha-katab...Montreal
Photo of Maha Katabi, General Partner at Sofinnova Investments
Your Intro Paths to Maha Katabi
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Maha Katabi on

cb
Current Investing Position
Sofinnova Investments General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
12

Maha Katabi is on these Sector & Stage Rankings

Maha Katabi's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Aaron Royston (venBio), Charles Homcy (Third Rock Ventures), Chris Garabedian (Perceptive Advisors), Jeffrey Tong (Third Rock Ventures)
Star Therapeutics
Series CSep 2023$90M
$90M
Co-investors: Carl Gordon (OrbiMed), Beth Seidenberg (Westlake Village BioPartners)
Quanta Therapeutics
Series DMay 2023$51M
$110M
Co-investors: Arjun Goyal (Vida Ventures)
RayzeBio
Series DSep 2022$160M
$420M
Co-investors: Jerel Davis (Versant Ventures), Aaron Royston (venBio), Bong Koh (Venrock), bong koh (KohFounders)
Gyroscope Therapeutics
Series CMar 2021$150M
$210M
Co-investors: Robert Tansley (Cambridge Innovation Capital), Wouter Joustra (Forbion), Dmitrij Hristodorov (Forbion)
Vera Therapeutics
Series CJan 2021$80M
Series UnknownJan 2020
$110M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Kurt von Emster (Abingworth), Beth Seidenberg (Westlake Village BioPartners)
Aerovate Therapeutics
Series AAug 2020$73M
$73M
Apellis Pharmaceuticals
Series EAug 2017$60M
$60M